Pre-made Cedelizumab benchmark antibody (Whole mAb, anti-CD4 therapeutic antibody, Anti-IMD79/OKT4D Antibody) for drug discovery and mechanism of action (MOA) research

Cat No.: GMP-Bios-INN-773

Anti-CD4 therapeutic antibody (Pre-made Cedelizumab biosimilar, Whole mAb) is a biosimilar expressed by mammalian cell line as a benchmark reference therapeutic antibody for biological drug disovery items including cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) and mechanism of action (MOA) research.

Cedelizumab is a monoclonal antibody acting on the immune system.[1] Possible indications include the prevention of organ transplant rejections and the treatment of autoimmune diseases.[2]

Order information


* GeneMedi provides NON-PROFIT PRICE to support Academic research. Please click inquiry for product quotation. → Inquiry

Catalog No. Package Price(In USD) Qty (Quantity) Sum(In USD)
GMP-Bios-INN-773-1mg 1mg 3090
GMP-Bios-INN-773-10mg 10mg Inquiry
GMP-Bios-INN-773-100mg 100mg Inquiry
GMP-Bios-INN-773-xmg ≥100mg Inquiry
Shipping Cost: 760.00
Total:

For more than 100mg, click here for inquiry. >>


Description

Products Name (INN Index) Pre-Made Cedelizumab Biosimilar, Whole Mab, Anti-Cd4 Antibody: Anti-IMD79/OKT4D therapeutic antibody
INN Name Cedelizumab
TargetCD4
FormatWhole mAb
DerivationHumanized
Species Reactivityhuman
CH1 IsotypeIgG4 - kappa
VD LCIgG4 - kappa
Highest_Clin_Trial (Jan '20)
Est. Status
100% SI Structure
99% SI Structure
95-98% SI Structure
Year Proposed
Year Recommended
CompaniesCentocor Ortho Biotech Products LP (Raritan NJ USA)
Conditions Approved
Conditions Active
Conditions Discontinued
Development Tech0